(a) Schematic of the in vivo CAR-T cell therapy process; (b) Clinically validated delivery platforms including LNP-based systems and viral vectors; (c) Emerging future directions for durable and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results